ClinicalTrials.govpublic full text
Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies
adult solid neoplasm, childhood solid neoplasm, recurrent childhood central nervous system neoplasm, recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor, recurrent malignant solid neoplasm, refractory central nervous system neoplasm, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 862065
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.